Financials Qingdao NovelBeam Technology Co.,Ltd.

Equities

688677

CNE100005410

Advanced Medical Equipment & Technology

End-of-day quote Shanghai S.E. 06:00:00 2024-05-15 pm EDT 5-day change 1st Jan Change
45.07 CNY +0.18% Intraday chart for Qingdao NovelBeam Technology Co.,Ltd. -5.30% -15.33%

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 8,185 9,829 6,475 5,428 - -
Enterprise Value (EV) 1 8,185 9,829 6,475 5,428 5,428 5,428
P/E ratio 66.7 x 53.8 x 44.4 x 25.8 x 19.5 x 15.9 x
Yield 0.44% 0.71% 1.03% 1.33% 2% 2.29%
Capitalization / Revenue 26.4 x 20.6 x 13.8 x 8.89 x 6.7 x 5.65 x
EV / Revenue 26.4 x 20.6 x 13.8 x 8.89 x 6.7 x 5.65 x
EV / EBITDA 57.3 x 45.7 x 35.2 x 21.3 x 15.4 x 13.9 x
EV / FCF - 3,575,478,427 x - - - -
FCF Yield - 0% - - - -
Price to Book 7.5 x 8.06 x 5.01 x 3.74 x 3.15 x 2.72 x
Nbr of stocks (in thousands) 121,772 121,772 121,637 120,434 - -
Reference price 2 67.21 80.71 53.23 45.07 45.07 45.07
Announcement Date 4/25/22 2/24/23 2/23/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 - 309.7 476.8 470.6 610.6 810.6 961.1
EBITDA 1 - 142.8 214.9 183.8 254.8 353.2 391
EBIT 1 - 133.9 206.3 161 235 317.1 384.8
Operating Margin - 43.25% 43.27% 34.2% 38.48% 39.12% 40.04%
Earnings before Tax (EBT) 1 - 133.2 205.5 160.2 234.4 316.5 383.9
Net income 1 96.35 117.7 182.6 145.7 213.4 281.6 344.3
Net margin - 38.02% 38.29% 30.96% 34.95% 34.73% 35.82%
EPS 2 1.057 1.007 1.500 1.200 1.748 2.310 2.830
Free Cash Flow - - 2.749 - - - -
FCF margin - - 0.58% - - - -
FCF Conversion (EBITDA) - - 1.28% - - - -
FCF Conversion (Net income) - - 1.51% - - - -
Dividend per Share 2 - 0.2929 0.5714 0.5500 0.6000 0.9000 1.030
Announcement Date 3/26/21 4/25/22 2/24/23 2/23/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2024 Q1
Net sales 1 117.6
EBITDA -
EBIT -
Operating Margin -
Earnings before Tax (EBT) -
Net income 1 38.44
Net margin 32.68%
EPS -
Dividend per Share -
Announcement Date 4/24/24
1CNY in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - -
Net Cash position - - - - - - -
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow - - 2.75 - - - -
ROE (net income / shareholders' equity) - 12.7% 15.9% 11.6% 14.4% 16.2% 17.1%
ROA (Net income/ Total Assets) - 9.96% 14.2% 10.5% 13.5% 15.2% 17.1%
Assets 1 - 1,182 1,288 1,392 1,577 1,848 2,013
Book Value Per Share 2 - 8.960 10.00 10.60 12.10 14.30 16.60
Cash Flow per Share 2 - 0.8500 0.8600 1.300 1.690 2.300 2.530
Capex 1 - 100 102 55.9 44.4 75.9 44.4
Capex / Sales - 32.32% 21.31% 11.87% 7.26% 9.37% 4.62%
Announcement Date 3/26/21 4/25/22 2/24/23 2/23/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
45.07 CNY
Average target price
59 CNY
Spread / Average Target
+30.91%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688677 Stock
  4. Financials Qingdao NovelBeam Technology Co.,Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW